Mounjaro 2.5mg (Tirzepatide) Starting Dose for Metabolic Health is the initiation strength of Tirzepatide, a first-in-class dual GIP and GLP-1 receptor agonist. This once-weekly injection is designed to introduce the medication to your system, helping your body adjust to the dual-hormone signaling. While primarily used to start blood sugar regulation, it also begins the process of appetite suppression and digestive slowing. Key Highlights: Initiation Phase: Formulated to minimize gastrointestinal side effects during the first 4 weeks. Dual-Action Technology: Activates two separate hormone receptors for effective metabolic support. Gentle Start: Prepares the body for future therapeutic dose increases. Administration: Subcutaneous injection once weekly on the same day each week. Storage: Keep refrigerated between 2°C and 8°C. Store in the original carton to protect from light.